MedTrace Logo

A Study of the Efficacy and Safety of Abametapir Lotion Administered for the Treatment of Head Lice Infestation

NCT02060903 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 379

Last updated 2020-09-23

Study results available
· View outcomes & findings →

Summary

The purpose of the study was to assess the efficacy, safety and tolerability of a single application of abametapir lotion 0.74% w/w compared to a vehicle control, when applied to the scalp and hair for 10 minutes at home.

Conditions

  • Head Lice Infestation

Interventions

DRUG

Abametapir Lotion 0.74% w/w

Abametapir Lotion 0.74% was dispensed to subjects on Day 0 for self-administration at home on the same day.

DRUG

Vehicle Lotion

Vehicle Lotion was dispensed to subjects on Day 0 for self-administration at home on the same day.

Sponsors & Collaborators

  • Accelovance

    collaborator INDUSTRY

  • Syneos Health

    collaborator OTHER

  • Dr. Reddy's Laboratories Limited

    lead INDUSTRY

Principal Investigators

  • Srinivas Sidgiddi, MD · Dr. Reddy's Laboratories Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2014-07-31
Completion
2014-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02060903 on ClinicalTrials.gov